If your portfolio is properly positioned, you can respond calmly and rationally to unexpected external shocks and sharp downturns. Read More
Analyst Articles
The contrast in Q4 results between positive revenues and negative earnings is raising questions about net profit margins. Read More
Under the phase one trade deal, China must import considerably more U.S.-grown hemp. That’s good news for cannabis investors. Read More
Boeing's safety woes weigh on the Dow and underscore broader economic and trade problems that could worsen this year. Read More
The bulls are undeterred, despite high valuations and rising risks. That's a bad sign, but here's a correction-proof play. Read More
If certain bills pending in Congress are passed, the marijuana sector could soar. You need to get ahead of the curve. Read More
Avoid uttering these phrases about the markets. They’re commonly heard but utterly dumb. Read More
We interviewed one of our investment experts, to glean guidance for the year ahead. Some of his answers may surprise you. Read More
Here’s our weekly review of legal and regulatory activity regarding marijuana, on the federal and state levels. Read More
Investors are learning that the hyped “phase one” trade deal is hollow. To keep stocks afloat, the burden rests on Q4 earnings. Read More